WTC Aftermath

Finance: A winter of discontent

While the Sept. 11 attack has quickly spurred a frightening market selloff, the long term impact on biotech will reflect the relative strength of individual company balance sheets, coupled to the relative resolve of investors to stay with defensive plays in the big and perhaps mid-cap groups.

For public companies, the already robust PIPE market looks to be the vehicle of choice, while very early and very late stage plays may find favor in the private equity space.